nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0437	0.0783	CbGpPWpGaD
Alimemazine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.0158	0.0282	CbGpPWpGaD
Alimemazine—HRH1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.0135	0.0242	CbGpPWpGaD
Alimemazine—HRH1—Monoamine GPCRs—DRD1—Parkinson's disease	0.0131	0.0234	CbGpPWpGaD
Alimemazine—HRH1—Monoamine GPCRs—DRD3—Parkinson's disease	0.0126	0.0227	CbGpPWpGaD
Alimemazine—Benzphetamine—SLC18A2—Parkinson's disease	0.0126	0.0286	CrCbGaD
Alimemazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0122	0.0218	CbGpPWpGaD
Alimemazine—HRH1—Monoamine GPCRs—DRD2—Parkinson's disease	0.0114	0.0205	CbGpPWpGaD
Alimemazine—HRH1—Monoamine GPCRs—HTR7—Parkinson's disease	0.0114	0.0205	CbGpPWpGaD
Alimemazine—Acetophenazine—DRD1—Parkinson's disease	0.0114	0.0257	CrCbGaD
Alimemazine—HRH1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.0114	0.0204	CbGpPWpGaD
Alimemazine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.0113	0.0202	CbGpPWpGaD
Alimemazine—HRH1—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.011	0.0197	CbGpPWpGaD
Alimemazine—HRH1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.0106	0.019	CbGpPWpGaD
Alimemazine—Propericiazine—DRD1—Parkinson's disease	0.01	0.0227	CrCbGaD
Alimemazine—HRH1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.00961	0.0172	CbGpPWpGaD
Alimemazine—HRH1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.00961	0.0172	CbGpPWpGaD
Alimemazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00905	0.0162	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.00835	0.015	CbGpPWpGaD
Alimemazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00828	0.0148	CbGpPWpGaD
Alimemazine—Acetophenazine—DRD2—Parkinson's disease	0.00802	0.0181	CrCbGaD
Alimemazine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00801	0.0144	CbGpPWpGaD
Alimemazine—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00757	0.0136	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.00747	0.0134	CbGpPWpGaD
Alimemazine—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00745	0.0133	CbGpPWpGaD
Alimemazine—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00728	0.013	CbGpPWpGaD
Alimemazine—Triflupromazine—DRD1—Parkinson's disease	0.00697	0.0158	CrCbGaD
Alimemazine—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00692	0.0124	CbGpPWpGaD
Alimemazine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00673	0.0121	CbGpPWpGaD
Alimemazine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00666	0.0119	CbGpPWpGaD
Alimemazine—Clomipramine—GSTP1—Parkinson's disease	0.00649	0.0147	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00645	0.0116	CbGpPWpGaD
Alimemazine—Acepromazine—DRD1—Parkinson's disease	0.00645	0.0146	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.00633	0.0113	CbGpPWpGaD
Alimemazine—Thioproperazine—DRD1—Parkinson's disease	0.00631	0.0143	CrCbGaD
Alimemazine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00624	0.0112	CbGpPWpGaD
Alimemazine—Mesoridazine—DRD3—Parkinson's disease	0.00624	0.0141	CrCbGaD
Alimemazine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00622	0.0111	CbGpPWpGaD
Alimemazine—Pipotiazine—DRD1—Parkinson's disease	0.0062	0.014	CrCbGaD
Alimemazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00616	0.011	CbGpPWpGaD
Alimemazine—Prochlorperazine—DRD3—Parkinson's disease	0.00604	0.0137	CrCbGaD
Alimemazine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00571	0.0102	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00566	0.0101	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00553	0.00991	CbGpPWpGaD
Alimemazine—Cyamemazine—HTR2A—Parkinson's disease	0.00547	0.0124	CrCbGaD
Alimemazine—Acepromazine—HTR1A—Parkinson's disease	0.00536	0.0121	CrCbGaD
Alimemazine—Benzphetamine—SLC6A3—Parkinson's disease	0.00524	0.0119	CrCbGaD
Alimemazine—Thioproperazine—HTR1A—Parkinson's disease	0.00524	0.0118	CrCbGaD
Alimemazine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00523	0.00938	CbGpPWpGaD
Alimemazine—Propiomazine—DRD1—Parkinson's disease	0.00516	0.0117	CrCbGaD
Alimemazine—Pipotiazine—HTR1A—Parkinson's disease	0.00515	0.0117	CrCbGaD
Alimemazine—Cyclobenzaprine—HTR2A—Parkinson's disease	0.00509	0.0115	CrCbGaD
Alimemazine—Mesoridazine—HTR1A—Parkinson's disease	0.00509	0.0115	CrCbGaD
Alimemazine—Thioridazine—HTR7—Parkinson's disease	0.00501	0.0113	CrCbGaD
Alimemazine—Chlorprothixene—DRD3—Parkinson's disease	0.00497	0.0113	CrCbGaD
Alimemazine—Triflupromazine—DRD2—Parkinson's disease	0.00492	0.0111	CrCbGaD
Alimemazine—Chlorprothixene—DRD1—Parkinson's disease	0.00488	0.011	CrCbGaD
Alimemazine—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.00465	0.0105	CrCbGaD
Alimemazine—Thioridazine—DRD1—Parkinson's disease	0.00462	0.0105	CrCbGaD
Alimemazine—Perphenazine—HTR7—Parkinson's disease	0.00459	0.0104	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00457	0.0082	CbGpPWpGaD
Alimemazine—Acepromazine—DRD2—Parkinson's disease	0.00455	0.0103	CrCbGaD
Alimemazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00453	0.00812	CbGpPWpGaD
Alimemazine—Methotrimeprazine—DRD3—Parkinson's disease	0.00449	0.0102	CrCbGaD
Alimemazine—Thioproperazine—DRD2—Parkinson's disease	0.00445	0.0101	CrCbGaD
Alimemazine—Methotrimeprazine—DRD1—Parkinson's disease	0.00441	0.00998	CrCbGaD
Alimemazine—Pipotiazine—DRD2—Parkinson's disease	0.00437	0.0099	CrCbGaD
Alimemazine—Mequitazine—CYP2D6—Parkinson's disease	0.00435	0.00983	CrCbGaD
Alimemazine—Mesoridazine—DRD2—Parkinson's disease	0.00432	0.00977	CrCbGaD
Alimemazine—Trimipramine—SLC6A3—Parkinson's disease	0.00428	0.00968	CrCbGaD
Alimemazine—Perphenazine—DRD1—Parkinson's disease	0.00424	0.00959	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.00421	0.00755	CbGpPWpGaD
Alimemazine—Prochlorperazine—DRD2—Parkinson's disease	0.00418	0.00946	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00409	0.00733	CbGpPWpGaD
Alimemazine—Diltiazem—CYP2D6—Parkinson's disease	0.0039	0.00882	CrCbGaD
Alimemazine—Thioridazine—HTR1A—Parkinson's disease	0.00384	0.00868	CrCbGaD
Alimemazine—Promazine—DRD1—Parkinson's disease	0.00382	0.00865	CrCbGaD
Alimemazine—Trimipramine—HTR1A—Parkinson's disease	0.00375	0.00848	CrCbGaD
Alimemazine—Desipramine—SLC6A3—Parkinson's disease	0.00374	0.00846	CrCbGaD
Alimemazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00371	0.00665	CbGpPWpGaD
Alimemazine—Chlorpromazine—HTR7—Parkinson's disease	0.00365	0.00825	CrCbGaD
Alimemazine—Propiomazine—DRD2—Parkinson's disease	0.00364	0.00823	CrCbGaD
Alimemazine—Imipramine—HTR7—Parkinson's disease	0.00363	0.0082	CrCbGaD
Alimemazine—Amitriptyline—HTR7—Parkinson's disease	0.0036	0.00815	CrCbGaD
Alimemazine—Doxepin—HTR1A—Parkinson's disease	0.00357	0.00808	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00356	0.00639	CbGpPWpGaD
Alimemazine—Trifluoperazine—HTR1A—Parkinson's disease	0.00356	0.00805	CrCbGaD
Alimemazine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00356	0.00637	CbGpPWpGaD
Alimemazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00354	0.00634	CbGpPWpGaD
Alimemazine—Perphenazine—HTR1A—Parkinson's disease	0.00352	0.00797	CrCbGaD
Alimemazine—Acepromazine—HTR2A—Parkinson's disease	0.00352	0.00795	CrCbGaD
Alimemazine—Chlorprothixene—DRD2—Parkinson's disease	0.00344	0.00779	CrCbGaD
Alimemazine—Thioproperazine—HTR2A—Parkinson's disease	0.00344	0.00777	CrCbGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00343	0.00615	CbGpPWpGaD
Alimemazine—Chlorpromazine—DRD3—Parkinson's disease	0.00343	0.00775	CrCbGaD
Alimemazine—Amitriptyline—DRD3—Parkinson's disease	0.00339	0.00767	CrCbGaD
Alimemazine—Pipotiazine—HTR2A—Parkinson's disease	0.00338	0.00765	CrCbGaD
Alimemazine—Chlorpromazine—DRD1—Parkinson's disease	0.00336	0.00761	CrCbGaD
Alimemazine—Mesoridazine—HTR2A—Parkinson's disease	0.00334	0.00755	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00332	0.00596	CbGpPWpGaD
Alimemazine—Desipramine—HTR1A—Parkinson's disease	0.00328	0.00741	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00326	0.00584	CbGpPWpGaD
Alimemazine—Thioridazine—DRD2—Parkinson's disease	0.00326	0.00737	CrCbGaD
Alimemazine—Trimipramine—DRD2—Parkinson's disease	0.00318	0.0072	CrCbGaD
Alimemazine—Imipramine—SLC6A3—Parkinson's disease	0.00317	0.00718	CrCbGaD
Alimemazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00314	0.00563	CbGpPWpGaD
Alimemazine—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.00314	0.00711	CrCbGaD
Alimemazine—Thioridazine—CYP2E1—Parkinson's disease	0.00314	0.00709	CrCbGaD
Alimemazine—Methotrimeprazine—DRD2—Parkinson's disease	0.00311	0.00704	CrCbGaD
Alimemazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0031	0.00556	CbGpPWpGaD
Alimemazine—Pipotiazine—CYP2D6—Parkinson's disease	0.00309	0.00699	CrCbGaD
Alimemazine—Promethazine—DRD2—Parkinson's disease	0.00306	0.00693	CrCbGaD
Alimemazine—Mesoridazine—CYP2D6—Parkinson's disease	0.00305	0.0069	CrCbGaD
Alimemazine—Doxepin—DRD2—Parkinson's disease	0.00303	0.00686	CrCbGaD
Alimemazine—Trifluoperazine—DRD2—Parkinson's disease	0.00302	0.00684	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00301	0.00539	CbGpPWpGaD
Alimemazine—Methotrimeprazine—CYP2E1—Parkinson's disease	0.00299	0.00677	CrCbGaD
Alimemazine—Perphenazine—DRD2—Parkinson's disease	0.00299	0.00676	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00297	0.00533	CbGpPWpGaD
Alimemazine—Prochlorperazine—CYP2D6—Parkinson's disease	0.00295	0.00668	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00295	0.00528	CbGpPWpGaD
Alimemazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00288	0.00515	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.00286	0.00513	CbGpPWpGaD
Alimemazine—Orphenadrine—CYP2E1—Parkinson's disease	0.00284	0.00643	CrCbGaD
Alimemazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00284	0.00509	CbGpPWpGaD
Alimemazine—Propiomazine—HTR2A—Parkinson's disease	0.00281	0.00636	CrCbGaD
Alimemazine—Chlorpromazine—HTR1A—Parkinson's disease	0.00279	0.00632	CrCbGaD
Alimemazine—Diltiazem—ABCB1—Parkinson's disease	0.00278	0.0063	CrCbGaD
Alimemazine—Desipramine—DRD2—Parkinson's disease	0.00278	0.00629	CrCbGaD
Alimemazine—Imipramine—HTR1A—Parkinson's disease	0.00278	0.00629	CrCbGaD
Alimemazine—Amitriptyline—HTR1A—Parkinson's disease	0.00276	0.00625	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.00271	0.00486	CbGpPWpGaD
Alimemazine—Promazine—DRD2—Parkinson's disease	0.00269	0.0061	CrCbGaD
Alimemazine—Desipramine—CYP2E1—Parkinson's disease	0.00268	0.00606	CrCbGaD
Alimemazine—Clomipramine—HTR2A—Parkinson's disease	0.00267	0.00604	CrCbGaD
Alimemazine—Chlorprothixene—HTR2A—Parkinson's disease	0.00266	0.00602	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00264	0.00472	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00261	0.00468	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00258	0.00462	CbGpPWpGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00255	0.00457	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00252	0.00452	CbGpPWpGaD
Alimemazine—Thioridazine—HTR2A—Parkinson's disease	0.00252	0.00569	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.00248	0.00445	CbGpPWpGaD
Alimemazine—Triflupromazine—ABCB1—Parkinson's disease	0.00248	0.00561	CrCbGaD
Alimemazine—Trimipramine—HTR2A—Parkinson's disease	0.00246	0.00556	CrCbGaD
Alimemazine—Clomipramine—CYP2D6—Parkinson's disease	0.00244	0.00553	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00244	0.00437	CbGpPWpGaD
Alimemazine—Methotrimeprazine—HTR2A—Parkinson's disease	0.0024	0.00544	CrCbGaD
Alimemazine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00238	0.00426	CbGpPWpGaD
Alimemazine—Chlorpromazine—DRD2—Parkinson's disease	0.00237	0.00537	CrCbGaD
Alimemazine—Promethazine—HTR2A—Parkinson's disease	0.00237	0.00536	CrCbGaD
Alimemazine—Imipramine—DRD2—Parkinson's disease	0.00236	0.00534	CrCbGaD
Alimemazine—Amitriptyline—DRD2—Parkinson's disease	0.00234	0.0053	CrCbGaD
Alimemazine—Doxepin—HTR2A—Parkinson's disease	0.00234	0.0053	CrCbGaD
Alimemazine—Trifluoperazine—HTR2A—Parkinson's disease	0.00234	0.00528	CrCbGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00233	0.00418	CbGpPWpGaD
Alimemazine—Perphenazine—HTR2A—Parkinson's disease	0.00231	0.00523	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.00231	0.00413	CbGpPWpGaD
Alimemazine—Thioridazine—CYP2D6—Parkinson's disease	0.0023	0.00521	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00229	0.0041	CbGpPWpGaD
Alimemazine—Chlorpromazine—CYP2E1—Parkinson's disease	0.00228	0.00516	CrCbGaD
Alimemazine—Imipramine—CYP2E1—Parkinson's disease	0.00227	0.00514	CrCbGaD
Alimemazine—Amitriptyline—CYP2E1—Parkinson's disease	0.00226	0.00511	CrCbGaD
Alimemazine—Trimipramine—CYP2D6—Parkinson's disease	0.00225	0.00509	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00224	0.00401	CbGpPWpGaD
Alimemazine—Diphenhydramine—CYP2D6—Parkinson's disease	0.00221	0.00499	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00221	0.00396	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00221	0.00396	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.0022	0.00395	CbGpPWpGaD
Alimemazine—Methotrimeprazine—CYP2D6—Parkinson's disease	0.0022	0.00497	CrCbGaD
Alimemazine—Promethazine—CYP2D6—Parkinson's disease	0.00216	0.0049	CrCbGaD
Alimemazine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00216	0.00387	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	0.00216	0.00387	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00216	0.00387	CbGpPWpGaD
Alimemazine—Desipramine—HTR2A—Parkinson's disease	0.00215	0.00486	CrCbGaD
Alimemazine—Doxepin—CYP2D6—Parkinson's disease	0.00214	0.00485	CrCbGaD
Alimemazine—Methadone—CYP2D6—Parkinson's disease	0.00213	0.00482	CrCbGaD
Alimemazine—Perphenazine—CYP2D6—Parkinson's disease	0.00211	0.00478	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00209	0.00375	CbGpPWpGaD
Alimemazine—Promazine—HTR2A—Parkinson's disease	0.00208	0.00471	CrCbGaD
Alimemazine—Carbamazepine—ABCB1—Parkinson's disease	0.00207	0.00468	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00204	0.00366	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00204	0.00366	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00202	0.00361	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.002	0.00358	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00198	0.00354	CbGpPWpGaD
Alimemazine—Desipramine—CYP2D6—Parkinson's disease	0.00197	0.00445	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00196	0.00352	CbGpPWpGaD
Alimemazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00192	0.00344	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00189	0.00339	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00189	0.00339	CbGpPWpGaD
Alimemazine—Chlorpromazine—HTR2A—Parkinson's disease	0.00183	0.00415	CrCbGaD
Alimemazine—Imipramine—HTR2A—Parkinson's disease	0.00182	0.00412	CrCbGaD
Alimemazine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00182	0.00326	CbGpPWpGaD
Alimemazine—Amitriptyline—HTR2A—Parkinson's disease	0.00181	0.0041	CrCbGaD
Alimemazine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.0018	0.00323	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00179	0.00321	CbGpPWpGaD
Alimemazine—Clomipramine—ABCB1—Parkinson's disease	0.00174	0.00395	CrCbGaD
Alimemazine—Chlorprothixene—ABCB1—Parkinson's disease	0.00174	0.00393	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.0017	0.00305	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.00168	0.003	CbGpPWpGaD
Alimemazine—Chlorpromazine—CYP2D6—Parkinson's disease	0.00168	0.00379	CrCbGaD
Alimemazine—Imipramine—CYP2D6—Parkinson's disease	0.00167	0.00377	CrCbGaD
Alimemazine—Amitriptyline—CYP2D6—Parkinson's disease	0.00166	0.00375	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.00164	0.00295	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.00164	0.00293	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00162	0.0029	CbGpPWpGaD
Alimemazine—Trimipramine—ABCB1—Parkinson's disease	0.00161	0.00363	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.00159	0.00285	CbGpPWpGaD
Alimemazine—Promethazine—ABCB1—Parkinson's disease	0.00155	0.0035	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00155	0.00277	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.00154	0.00276	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.00153	0.00275	CbGpPWpGaD
Alimemazine—Doxepin—ABCB1—Parkinson's disease	0.00153	0.00346	CrCbGaD
Alimemazine—Trifluoperazine—ABCB1—Parkinson's disease	0.00153	0.00345	CrCbGaD
Alimemazine—Methadone—ABCB1—Parkinson's disease	0.00152	0.00344	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00151	0.00271	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	0.00147	0.00263	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	0.00144	0.00258	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	0.00144	0.00258	CbGpPWpGaD
Alimemazine—Desipramine—ABCB1—Parkinson's disease	0.0014	0.00318	CrCbGaD
Alimemazine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	0.0014	0.00251	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	0.00139	0.0025	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.00135	0.00243	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00134	0.00239	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00132	0.00237	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0013	0.00234	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	0.00128	0.00229	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	0.00128	0.00229	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	0.00127	0.00228	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00124	0.00222	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00122	0.00219	CbGpPWpGaD
Alimemazine—Chlorpromazine—ABCB1—Parkinson's disease	0.0012	0.00271	CrCbGaD
Alimemazine—Imipramine—ABCB1—Parkinson's disease	0.00119	0.00269	CrCbGaD
Alimemazine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	0.00118	0.00212	CbGpPWpGaD
Alimemazine—Amitriptyline—ABCB1—Parkinson's disease	0.00118	0.00268	CrCbGaD
Alimemazine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00117	0.00209	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	0.00115	0.00207	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00111	0.00199	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.00103	0.00184	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.00102	0.00183	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	0.00102	0.00183	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.00102	0.00183	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.00101	0.00181	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00101	0.00181	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00101	0.0018	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00101	0.0018	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	0.000967	0.00173	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000962	0.00172	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000947	0.0017	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000938	0.00168	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000929	0.00166	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000925	0.00166	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	0.0009	0.00161	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000873	0.00157	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	0.000868	0.00156	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	0.00086	0.00154	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	0.000844	0.00151	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00084	0.00151	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAG—Parkinson's disease	0.000823	0.00147	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PENK—Parkinson's disease	0.000823	0.00147	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	0.000817	0.00146	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000814	0.00146	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000814	0.00146	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000763	0.00137	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	0.000752	0.00135	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	0.000739	0.00132	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	0.000739	0.00132	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	0.000707	0.00127	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	0.000699	0.00125	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000665	0.00119	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000665	0.00119	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000651	0.00117	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000625	0.00112	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000625	0.00112	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000621	0.00111	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	0.000613	0.0011	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000595	0.00107	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000593	0.00106	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	0.000592	0.00106	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00057	0.00102	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000566	0.00101	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—INSR—Parkinson's disease	0.000549	0.000984	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGB—Parkinson's disease	0.000519	0.00093	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000518	0.000927	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	0.000516	0.000925	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	0.000508	0.000911	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000504	0.000904	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000504	0.000904	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000504	0.000904	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	0.000498	0.000893	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	0.000483	0.000865	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000451	0.000808	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	0.000436	0.000782	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	0.000436	0.000782	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—DDC—Parkinson's disease	0.00037	0.000663	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	0.000366	0.000656	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	0.000354	0.000634	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000349	0.000626	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	0.000349	0.000626	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NGF—Parkinson's disease	0.000321	0.000576	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000315	0.000564	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000311	0.000558	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	0.000306	0.000548	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APOE—Parkinson's disease	0.000284	0.000509	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—INS—Parkinson's disease	0.000243	0.000435	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000232	0.000415	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000227	0.000407	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000212	0.000379	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000209	0.000375	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TH—Parkinson's disease	0.000206	0.00037	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000198	0.000355	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	0.000181	0.000324	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	0.00018	0.000322	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000175	0.000314	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000175	0.000313	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000174	0.000312	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000172	0.000309	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	0.000166	0.000298	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000165	0.000296	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.00016	0.000288	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000154	0.000275	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000142	0.000254	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—APOE—Parkinson's disease	0.000132	0.000237	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—INS—Parkinson's disease	0.000113	0.000202	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL6—Parkinson's disease	0.000106	0.00019	CbGpPWpGaD
